Seth Klarman: portfolio of Baupost Group

Seth Klarman leads the Baupost Group, which follows a value approach and looks for securities trading below their estimated worth.

Source: 13F filing with the US Securities and Exchange Commission dated Nov 13, 2020. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q3 2020. Go to the latest filing (Q3 2026)

9.2B USDQ3 2020
Total value of stock positions
9.2B USD
Positions
36
Share of the ten largest
66.4%

The ten largest positions Q3 2020

  1. eBay Inc. 17.0%▼ −6.1%
  2. Liberty Global PLC 12.1%unchanged
  3. Fox Corporation (Class A) 8.1%▼ −1.3%
  4. Viasat Inc 6.1%▲ +18.6%
  5. Viacomcbs Inc 5.7%unchanged
  6. Pershing Square Tontine Hldg 4.3%new
  7. Qorvo Inc 4.1%▼ −3.3%
  8. PG&E Corporation 3.1%▲ +552.0%
  9. Hd Supply HLDGS Inc 3.0%▲ +3.0%
  10. HP Inc. 2.7%▼ −26.1%
Total value of stock positions per quarter, Q2 2013 to Q3 2026 (peak 12.7B USD).
Choose a quarter (54 filings)

All positions Q3 2020

Positions Q3 2020 per 13F filing, 9 of 9
Symbol Weight Shares Reported value Change Held since
EBAY eBay Inc. 17.0% 30,115,223 1.6B USD −6.1% reduced Q4 2018 8 quarters
FOXA Fox Corporation (Class A) 8.1% 26,972,720 750.7M USD −1.3% reduced Q1 2019 7 quarters
Qorvo Inc 4.1% 2,962,886 382.2M USD −3.3% reduced Q1 2017 15 quarters
HPQ HP Inc. 2.7% 13,300,000 252.6M USD −26.1% reduced Q4 2019 4 quarters
GOOG Alphabet Inc. (Class C) 2.5% 154,580 227.2M USD −28.0% reduced Q1 2020 3 quarters
META Meta Platforms 1.6% 563,000 147.5M USD −33.9% reduced Q1 2020 3 quarters
Theravance Biopharma Inc 1.4% 8,735,168 129.1M USD −6.2% reduced Q2 2014 26 quarters
Colony Cap Inc New 0.7% 22,622,503 61.8M USD −11.9% reduced Q2 2018 10 quarters
Vista Oil & Gas S A B De C V 0.1% 4,416,900 9.9M USD −25.9% reduced Q3 2019 5 quarters

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Plus 1 position in convertible bonds and bonds worth 26.3M USD as reported – not included in the weights.

Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.

  • Theravance Biopharma Inc principal 30.0M USD 26.3M USD

Breakdown by sector

  • Consumer Discretionary 17.0%
  • Communication Services 13.9%
  • Technology 6.9%
  • Utilities 3.1%
  • Health Care 2.7%
  • Real Estate 1.2%
  • Industrials 0.8%
  • not in our coverage 54.4%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close